These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31679174)

  • 1. Sequencing two Tyr::CreER
    Aktary Z; Corvelo A; Estrin C; Larue L
    Pigment Cell Melanoma Res; 2020 May; 33(3):426-434. PubMed ID: 31679174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient mapping of transgene integration sites and local structural changes in Cre transgenic mice using targeted locus amplification.
    Cain-Hom C; Splinter E; van Min M; Simonis M; van de Heijning M; Martinez M; Asghari V; Cox JC; Warming S
    Nucleic Acids Res; 2017 May; 45(8):e62. PubMed ID: 28053125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Autosomal
    Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
    Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
    Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
    Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
    J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten
    Deken MA; Song JY; Gadiot J; Bins AD; Kroon P; Verbrugge I; Blank CU
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
    Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
    Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Adult Vestibular Organs in 11 CreER Mouse Lines.
    Stone JS; Wisner SR; Bucks SA; Mellado Lagarde MM; Cox BC
    J Assoc Res Otolaryngol; 2018 Aug; 19(4):381-399. PubMed ID: 29869046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fidelity
    Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
    Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis.
    Zhang L; Zhang B; Han SJ; Shore AN; Rosen JM; Demayo FJ; Xin L
    Transgenic Res; 2012 Oct; 21(5):1117-23. PubMed ID: 22350718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted knock-in of CreER
    Kesavan G; Hammer J; Hans S; Brand M
    Cell Tissue Res; 2018 Apr; 372(1):41-50. PubMed ID: 29435650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel CreER
    Stüfchen I; Beckervordersandforth R; Fischer S; Kappelmann-Fenzl M; Bosserhoff AK; Beyer F
    Pigment Cell Melanoma Res; 2022 Nov; 35(6):613-621. PubMed ID: 35920064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal lineage mapping of follicular melanocytes with the Tyr::CreER(T) (2) transgene.
    Harris ML; Pavan WJ
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):269-74. PubMed ID: 23176440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Toxicity and Impaired Stem Cell Function after Conditional Activation of CreER
    Bohin N; Carlson EA; Samuelson LC
    Stem Cell Reports; 2018 Dec; 11(6):1337-1346. PubMed ID: 30449703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
    Xu J; Yao G; Ru Y; Xie S
    Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.
    Zhu M; Chen M; Lichtler AC; O'Keefe RJ; Chen D
    Osteoarthritis Cartilage; 2008 Jan; 16(1):129-30. PubMed ID: 17888690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.
    Bosenberg M; Muthusamy V; Curley DP; Wang Z; Hobbs C; Nelson B; Nogueira C; Horner JW; Depinho R; Chin L
    Genesis; 2006 May; 44(5):262-7. PubMed ID: 16676322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transgenic Alx4-CreER mouse to analyze anterior limb and nephric duct development.
    Rockwell DM; O'Connor AK; Bentley-Ford MR; Haycraft CJ; Croyle MJ; Brewer KM; Berbari NF; Kesterson RA; Yoder BK
    Dev Dyn; 2022 Sep; 251(9):1524-1534. PubMed ID: 33728725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.